搜索医学 AI 论文与资源

ICLR 2026 Poster accepted paper at ICLR 2026. Anomaly detection is a critical task in computer vision with profound implications for medical imaging, where identifying pathologies early can directly impact patient outcomes. While recent unsupervised anomaly detection approaches show promise, they require substantial normal training data and struggle to generalize across anatomical contexts. We introduce D$^2$4FAD, a novel dual distillation framework for few-shot anomaly detection that identifies anomalies in previously unseen tasks using only a small number of normal reference images. Our approach leverages a pre-trained encoder as a teacher network to extract multi-scale features from both support and query images, while a student decoder learns to distill knowledge from the teacher on query images and self-distill on support images. Code/project link: https://github.com/ttttqz/D24FAD

ICLR 2026 Poster accepted paper at ICLR 2026. Predicting individualized potential outcomes in sequential decision-making is central for optimizing therapeutic decisions in personalized medicine (e.g., which dosing sequence to give to a cancer patient). However, predicting potential out- comes over long horizons is notoriously difficult. Existing methods that break the curse of the horizon typically lack strong theoretical guarantees such as orthogonality and quasi-oracle efficiency. In this paper, we revisit the problem of predicting individualized potential outcomes in sequential decision-making (i.e., estimating Q-functions in Markov decision processes with observational data) through a causal inference lens.

ICLR 2026 Poster accepted paper at ICLR 2026. Estimating heterogeneous treatment effects (HTEs) from right-censored survival data is critical in high-stakes applications such as precision medicine and individualized policy-making. Yet, the survival analysis setting poses unique challenges for HTE estimation due to censoring, unobserved counterfactuals, and complex identification assumptions. Despite recent advances, from causal survival forests to survival meta-learners and outcome imputation approaches, evaluation practices remain fragmented and inconsistent. We introduce SurvHTE‐Bench, the first comprehensive benchmark for HTE estimation with censored outcomes. The benchmark spans (i) a modular suite of synthetic datasets with known ground truth, systematically varying causal assumptions and survival dynamics, (ii) semi-synthetic datasets that pair real-world covariates with simulated treatments and outcomes, and (iii) real-world datasets from a twin study (with known ground truth) and from an HIV clinical trial.

ICLR 2026 Poster accepted paper at ICLR 2026. Estimating potential outcomes for treatments over time based on observational data is important for personalized decision-making in medicine. However, many existing methods for this task fail to properly adjust for time-varying confounding and thus yield biased estimates. There are only a few neural methods with proper adjustments, but these have inherent limitations (e.g., division by propensity scores that are often close to zero), which result in poor performance. As a remedy, we introduce the iterative G-computation network (IGC-Net). Our IGC-Net is a novel, neural end-to-end model which adjusts for time-varying confounding in order to estimate conditional average potential outcomes (CAPOs) over time.

ICLR 2026 Poster accepted paper at ICLR 2026. Conditional generation models for longitudinal sequences can produce new or modified trajectories given a conditioning input. However, they often lack control over when the condition should take effect (timing) and which variables it should influence (scope). Most methods either operate only on univariate sequences or assume that the condition alters all variables and time steps. In scientific and clinical settings, interventions instead begin at a specific moment, such as the time of drug administration or surgery, and influence only a subset of measurements while the rest of the trajectory remains unchanged.

ICLR 2026 Poster accepted paper at ICLR 2026. The integration of histology images and gene profiles has shown great promise for improving survival prediction in cancer. However, current approaches often struggle to model intra- and inter-modal interactions efficiently and effectively due to the high dimensionality and complexity of the inputs. A major challenge is capturing critical prognostic events that, though few, underlie the complexity of the observed inputs and largely determine patient outcomes. These events---manifested as high-level structural signals such as spatial histologic patterns or pathway co-activations---are typically sparse, patient-specific, and unannotated, making them inherently difficult to uncover.

ICLR 2026 Poster accepted paper at ICLR 2026. Epilepsy affects over 50 million people worldwide, and one-third of patients suffer drug-resistant seizures where surgery offers the best chance of seizure freedom. Accurate localization of the epileptogenic zone (EZ) relies on intracranial EEG (iEEG). Clinical workflows, however, remain constrained by labor-intensive manual review. At the same time, existing data-driven approaches are typically developed on single-center datasets that are inconsistent in format and metadata, lack standardized benchmarks, and rarely release pathological event annotations, creating barriers to reproducibility, cross-center validation, and clinical relevance. Code/project link: https://omni-ieeg.github.io/omni-ieeg/; https://github.com/Omni-iEEG/Omni-iEEG

The PhysioNet/CinC Challenge 2012 dataset contains ICU time-series records used for mortality prediction and patient-specific outcome modeling. It remains a useful benchmark for clinical time-series modeling, missingness-aware learning, and early warning model development.

This Nature Portfolio / npj Digital Medicine collection is open for submissions until 2026-06-03. It invites research on real-world clinical performance of AI, including clinical utility, safety, reliability, equity, generalizability, workflow integration, post-deployment monitoring, transparency, patient-centered outcomes, and clinician-AI interaction.

Stanford MED277 / CS337 AI-Assisted Health Care examines how to move technical advances into clinical settings, choose the right healthcare problems, and improve outcomes that matter. It is geared toward learners who want to use AI and machine learning for real-world human health impact.